IN2012DN03042A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03042A IN2012DN03042A IN3042DEN2012A IN2012DN03042A IN 2012DN03042 A IN2012DN03042 A IN 2012DN03042A IN 3042DEN2012 A IN3042DEN2012 A IN 3042DEN2012A IN 2012DN03042 A IN2012DN03042 A IN 2012DN03042A
- Authority
- IN
- India
- Prior art keywords
- neuropeptide
- obesity
- diabetes
- substituents
- fragments
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25089609P | 2009-10-13 | 2009-10-13 | |
| PCT/EP2010/065060 WO2011045232A2 (en) | 2009-10-13 | 2010-10-08 | Neuropeptide-2 receptor (y-2r) agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03042A true IN2012DN03042A (es) | 2015-07-31 |
Family
ID=43478048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3042DEN2012 IN2012DN03042A (es) | 2009-10-13 | 2010-10-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110172147A1 (es) |
| EP (1) | EP2488195A2 (es) |
| JP (1) | JP2013507414A (es) |
| CN (1) | CN102596228A (es) |
| CA (1) | CA2776302A1 (es) |
| IN (1) | IN2012DN03042A (es) |
| WO (1) | WO2011045232A2 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS56998B1 (sr) | 2010-12-16 | 2018-05-31 | Novo Nordisk As | Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline |
| LT2827885T (lt) | 2012-03-22 | 2018-10-10 | Novo Nordisk A/S | Glp-1 peptidų kompozicijos ir jų gavimas |
| EP2708243A1 (en) * | 2012-09-17 | 2014-03-19 | OntoChem GmbH | Receptor ligand linked cytotoxic molecules |
| JP6672140B2 (ja) | 2013-05-02 | 2020-03-25 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１化合物の経口投薬 |
| GB201315335D0 (en) | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
| CN105722526B (zh) | 2013-11-15 | 2020-12-08 | 诺和诺德股份有限公司 | 选择性pyy化合物及其用途 |
| CN105764919B (zh) | 2013-11-15 | 2021-04-27 | 诺和诺德股份有限公司 | 在位置35具有β-高精氨酸置换的hPYY(1-36) |
| MA41898A (fr) * | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| CN107849110B (zh) | 2015-06-12 | 2021-11-26 | 诺和诺德股份有限公司 | 选择性pyy化合物及其用途 |
| MX2020007598A (es) | 2018-02-02 | 2020-09-03 | Novo Nordisk As | Composiciones solidas que comprenden un agonista del peptido similar al glucagon tipo 1 (glp-1), una sal del acido n-(8-(2-hidroxibenzoil)amino)caprilico y un lubricante. |
| CN109678930B (zh) * | 2018-12-05 | 2022-04-29 | 西北工业大学 | 聚乙二醇修饰的npff及其用途 |
| CN120092752A (zh) * | 2025-05-09 | 2025-06-06 | 北京大学人民医院 | 三叉神经痛动物模型及其构建方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB779829A (en) | 1953-11-20 | 1957-07-24 | Ciba Ltd | Polyglycol ethers and their manufacture |
| BE667886A (es) | 1965-04-23 | |||
| US5080891A (en) * | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5962263A (en) * | 1998-01-08 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Human membrane recycling proteins |
| US20030229013A1 (en) * | 2001-12-07 | 2003-12-11 | Shih-Kwang Wu | Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| RU2527893C2 (ru) | 2004-07-19 | 2014-09-10 | Биокон Лимитед | Инсулин-олигомерные конъюгаты, их препараты и применения |
| WO2006049681A2 (en) * | 2004-08-30 | 2006-05-11 | Bayer Pharmaceuticals Corporation | Selective neuropeptide y2 receptor agonists |
| US7410949B2 (en) * | 2005-01-18 | 2008-08-12 | Hoffmann-La Roche Inc. | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
| WO2006091505A2 (en) * | 2005-02-24 | 2006-08-31 | Bayer Pharmaceuticals Corporation | Neuropeptide y receptor agonists |
| BRPI0619573A2 (pt) * | 2005-12-07 | 2011-10-04 | Hoffmann La Roche | agonista receptor de neuropeptìdeo-2, formulações farmacêuticas, uso de agonista receptor de neuropeptìdeo-2 e método de tratamento de uma doença modulada por agonistas receptores de neuropeptìdeos-2 |
| CA2699366C (en) * | 2007-09-11 | 2013-12-03 | Nicolai Bovin | Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| CN102202681A (zh) * | 2008-11-05 | 2011-09-28 | 霍夫曼-拉罗奇有限公司 | 神经肽-2受体(y-2r)激动剂及其用途 |
-
2010
- 2010-10-08 CN CN2010800462458A patent/CN102596228A/zh active Pending
- 2010-10-08 IN IN3042DEN2012 patent/IN2012DN03042A/en unknown
- 2010-10-08 CA CA2776302A patent/CA2776302A1/en not_active Abandoned
- 2010-10-08 JP JP2012533580A patent/JP2013507414A/ja not_active Ceased
- 2010-10-08 WO PCT/EP2010/065060 patent/WO2011045232A2/en not_active Ceased
- 2010-10-08 EP EP10770751A patent/EP2488195A2/en not_active Withdrawn
-
2011
- 2011-03-25 US US13/072,048 patent/US20110172147A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2488195A2 (en) | 2012-08-22 |
| WO2011045232A3 (en) | 2011-06-16 |
| US20110172147A1 (en) | 2011-07-14 |
| JP2013507414A (ja) | 2013-03-04 |
| WO2011045232A2 (en) | 2011-04-21 |
| CN102596228A (zh) | 2012-07-18 |
| CA2776302A1 (en) | 2011-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03042A (es) | ||
| WO2010052144A3 (en) | Neuropeptide-2-receptor (y-2r) agonists and uses thereof | |
| TW200806311A (en) | Neuropeptide-2 receptor-agonists | |
| TW200637874A (en) | Peptides with neuropeptide-2 receptor (Y2R) agonist activity | |
| MX2009007180A (es) | Agonistas del receptor acoplado a la proteina g de la piperidina. | |
| MX2009012285A (es) | Inhibidores de diacilglicerol aciltransferasa. | |
| MY149622A (en) | Pyrazoles as 11-beta-hsd-1 | |
| MX2009011802A (es) | Imidazoquinolinas con propiedades inmunomoduladoras. | |
| IL187005A0 (en) | Diacylglycerol acyltransferase inhibitors | |
| GB0812642D0 (en) | Compounds | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| MY147994A (en) | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors | |
| IN2012DN03182A (es) | ||
| NZ608116A (en) | Triazine-oxadiazoles | |
| GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
| IN2012DN02139A (es) | ||
| MX2012000704A (es) | Agonistas de gpr119. | |
| MX2009000169A (es) | Derivados de purinona como agonistas de hm74a. | |
| MX2010006108A (es) | Inhibidores de estearoil-coa-desaturasa. | |
| MY160728A (en) | Morpholinothiazoles as alpha 7 positive allosteric modulators | |
| PH12012500622A1 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| MX2013008431A (es) | Antagonista del receptor de mineralocorticoides. | |
| PH12013502204A1 (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| TN2013000413A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes |